Global Sulphonamides Market Insights and Forecast to 2031

Report ID: 1197152 | Published Date: Jan 2025 | No. of Page: 111 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Sulphonamides Product Introduction
    1.2 Market by Type
        1.2.1 Global Sulphonamides Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Orally Absorbable Sulfonamide
        1.2.3 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
        1.2.4 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
    1.3 Market by Application
        1.3.1 Global Sulphonamides Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Skin Infections
        1.3.3 Gastro Intestinal Tract (GIT) Infection
        1.3.4 Meningitis
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Sulphonamides Sales Estimates and Forecasts 2017-2028
    2.2 Global Sulphonamides Revenue Estimates and Forecasts 2017-2028
    2.3 Global Sulphonamides Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Sulphonamides Sales by Region
        2.4.1 Global Sulphonamides Sales by Region (2017-2022)
        2.4.2 Global Sales Sulphonamides by Region (2023-2028)
    2.5 Global Sulphonamides Revenue by Region
        2.5.1 Global Sulphonamides Revenue by Region (2017-2022)
        2.5.2 Global Sulphonamides Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Sulphonamides Sales by Manufacturers
        3.1.1 Global Top Sulphonamides Manufacturers by Sales (2017-2022)
        3.1.2 Global Sulphonamides Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sulphonamides in 2021
    3.2 Global Sulphonamides Revenue by Manufacturers
        3.2.1 Global Sulphonamides Revenue by Manufacturers (2017-2022)
        3.2.2 Global Sulphonamides Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Sulphonamides Revenue in 2021
    3.3 Global Sulphonamides Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Sulphonamides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Sulphonamides Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Sulphonamides Sales by Type
        4.1.1 Global Sulphonamides Historical Sales by Type (2017-2022)
        4.1.2 Global Sulphonamides Forecasted Sales by Type (2023-2028)
        4.1.3 Global Sulphonamides Sales Market Share by Type (2017-2028)
    4.2 Global Sulphonamides Revenue by Type
        4.2.1 Global Sulphonamides Historical Revenue by Type (2017-2022)
        4.2.2 Global Sulphonamides Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Sulphonamides Revenue Market Share by Type (2017-2028)
    4.3 Global Sulphonamides Price by Type
        4.3.1 Global Sulphonamides Price by Type (2017-2022)
        4.3.2 Global Sulphonamides Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Sulphonamides Sales by Application
        5.1.1 Global Sulphonamides Historical Sales by Application (2017-2022)
        5.1.2 Global Sulphonamides Forecasted Sales by Application (2023-2028)
        5.1.3 Global Sulphonamides Sales Market Share by Application (2017-2028)
    5.2 Global Sulphonamides Revenue by Application
        5.2.1 Global Sulphonamides Historical Revenue by Application (2017-2022)
        5.2.2 Global Sulphonamides Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Sulphonamides Revenue Market Share by Application (2017-2028)
    5.3 Global Sulphonamides Price by Application
        5.3.1 Global Sulphonamides Price by Application (2017-2022)
        5.3.2 Global Sulphonamides Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Sulphonamides Market Size by Type
        6.1.1 North America Sulphonamides Sales by Type (2017-2028)
        6.1.2 North America Sulphonamides Revenue by Type (2017-2028)
    6.2 North America Sulphonamides Market Size by Application
        6.2.1 North America Sulphonamides Sales by Application (2017-2028)
        6.2.2 North America Sulphonamides Revenue by Application (2017-2028)
    6.3 North America Sulphonamides Market Size by Country
        6.3.1 North America Sulphonamides Sales by Country (2017-2028)
        6.3.2 North America Sulphonamides Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Sulphonamides Market Size by Type
        7.1.1 Europe Sulphonamides Sales by Type (2017-2028)
        7.1.2 Europe Sulphonamides Revenue by Type (2017-2028)
    7.2 Europe Sulphonamides Market Size by Application
        7.2.1 Europe Sulphonamides Sales by Application (2017-2028)
        7.2.2 Europe Sulphonamides Revenue by Application (2017-2028)
    7.3 Europe Sulphonamides Market Size by Country
        7.3.1 Europe Sulphonamides Sales by Country (2017-2028)
        7.3.2 Europe Sulphonamides Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Sulphonamides Market Size by Type
        8.1.1 Asia Pacific Sulphonamides Sales by Type (2017-2028)
        8.1.2 Asia Pacific Sulphonamides Revenue by Type (2017-2028)
    8.2 Asia Pacific Sulphonamides Market Size by Application
        8.2.1 Asia Pacific Sulphonamides Sales by Application (2017-2028)
        8.2.2 Asia Pacific Sulphonamides Revenue by Application (2017-2028)
    8.3 Asia Pacific Sulphonamides Market Size by Region
        8.3.1 Asia Pacific Sulphonamides Sales by Region (2017-2028)
        8.3.2 Asia Pacific Sulphonamides Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Sulphonamides Market Size by Type
        9.1.1 Latin America Sulphonamides Sales by Type (2017-2028)
        9.1.2 Latin America Sulphonamides Revenue by Type (2017-2028)
    9.2 Latin America Sulphonamides Market Size by Application
        9.2.1 Latin America Sulphonamides Sales by Application (2017-2028)
        9.2.2 Latin America Sulphonamides Revenue by Application (2017-2028)
    9.3 Latin America Sulphonamides Market Size by Country
        9.3.1 Latin America Sulphonamides Sales by Country (2017-2028)
        9.3.2 Latin America Sulphonamides Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Sulphonamides Market Size by Type
        10.1.1 Middle East and Africa Sulphonamides Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Sulphonamides Revenue by Type (2017-2028)
    10.2 Middle East and Africa Sulphonamides Market Size by Application
        10.2.1 Middle East and Africa Sulphonamides Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Sulphonamides Revenue by Application (2017-2028)
    10.3 Middle East and Africa Sulphonamides Market Size by Country
        10.3.1 Middle East and Africa Sulphonamides Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Sulphonamides Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Corporation Information
        11.1.2 Abbott Laboratories Overview
        11.1.3 Abbott Laboratories Sulphonamides Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Abbott Laboratories Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Abbott Laboratories Recent Developments
    11.2 Boehringer Ingelheim Pharmaceuticals
        11.2.1 Boehringer Ingelheim Pharmaceuticals Corporation Information
        11.2.2 Boehringer Ingelheim Pharmaceuticals Overview
        11.2.3 Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Boehringer Ingelheim Pharmaceuticals Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Boehringer Ingelheim Pharmaceuticals Recent Developments
    11.3 Bayer AG
        11.3.1 Bayer AG Corporation Information
        11.3.2 Bayer AG Overview
        11.3.3 Bayer AG Sulphonamides Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Bayer AG Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Bayer AG Recent Developments
    11.4 GlaxoSmithKline
        11.4.1 GlaxoSmithKline Corporation Information
        11.4.2 GlaxoSmithKline Overview
        11.4.3 GlaxoSmithKline Sulphonamides Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 GlaxoSmithKline Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 GlaxoSmithKline Recent Developments
    11.5 King Pharmaceuticals
        11.5.1 King Pharmaceuticals Corporation Information
        11.5.2 King Pharmaceuticals Overview
        11.5.3 King Pharmaceuticals Sulphonamides Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 King Pharmaceuticals Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 King Pharmaceuticals Recent Developments
    11.6 Mylan Pharmaceuticals
        11.6.1 Mylan Pharmaceuticals Corporation Information
        11.6.2 Mylan Pharmaceuticals Overview
        11.6.3 Mylan Pharmaceuticals Sulphonamides Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Mylan Pharmaceuticals Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Mylan Pharmaceuticals Recent Developments
    11.7 Novartis International AG
        11.7.1 Novartis International AG Corporation Information
        11.7.2 Novartis International AG Overview
        11.7.3 Novartis International AG Sulphonamides Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Novartis International AG Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Novartis International AG Recent Developments
    11.8 Pfizer
        11.8.1 Pfizer Corporation Information
        11.8.2 Pfizer Overview
        11.8.3 Pfizer Sulphonamides Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Pfizer Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Pfizer Recent Developments
    11.9 Par Pharmaceutical
        11.9.1 Par Pharmaceutical Corporation Information
        11.9.2 Par Pharmaceutical Overview
        11.9.3 Par Pharmaceutical Sulphonamides Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Par Pharmaceutical Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Par Pharmaceutical Recent Developments
    11.10 Roche Holding AG
        11.10.1 Roche Holding AG Corporation Information
        11.10.2 Roche Holding AG Overview
        11.10.3 Roche Holding AG Sulphonamides Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Roche Holding AG Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Roche Holding AG Recent Developments
    11.11 Sanofi Aventis
        11.11.1 Sanofi Aventis Corporation Information
        11.11.2 Sanofi Aventis Overview
        11.11.3 Sanofi Aventis Sulphonamides Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Sanofi Aventis Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Sanofi Aventis Recent Developments
    11.12 Stiefel Laboratories
        11.12.1 Stiefel Laboratories Corporation Information
        11.12.2 Stiefel Laboratories Overview
        11.12.3 Stiefel Laboratories Sulphonamides Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Stiefel Laboratories Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Stiefel Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Sulphonamides Industry Chain Analysis
    12.2 Sulphonamides Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Sulphonamides Production Mode & Process
    12.4 Sulphonamides Sales and Marketing
        12.4.1 Sulphonamides Sales Channels
        12.4.2 Sulphonamides Distributors
    12.5 Sulphonamides Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Sulphonamides Industry Trends
    13.2 Sulphonamides Market Drivers
    13.3 Sulphonamides Market Challenges
    13.4 Sulphonamides Market Restraints
14 Key Findings in The Global Sulphonamides Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Sulphonamides Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Orally Absorbable Sulfonamide
    Table 3. Major Manufacturers of Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
    Table 4. Major Manufacturers of Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
    Table 5. Global Sulphonamides Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Sulphonamides Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Sulphonamides Sales by Region (2017-2022) & (K MT)
    Table 8. Global Sulphonamides Sales Market Share by Region (2017-2022)
    Table 9. Global Sulphonamides Sales by Region (2023-2028) & (K MT)
    Table 10. Global Sulphonamides Sales Market Share by Region (2023-2028)
    Table 11. Global Sulphonamides Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Sulphonamides Revenue Market Share by Region (2017-2022)
    Table 13. Global Sulphonamides Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Sulphonamides Revenue Market Share by Region (2023-2028)
    Table 15. Global Sulphonamides Sales by Manufacturers (2017-2022) & (K MT)
    Table 16. Global Sulphonamides Sales Share by Manufacturers (2017-2022)
    Table 17. Global Sulphonamides Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Sulphonamides Revenue Share by Manufacturers (2017-2022)
    Table 19. Sulphonamides Price by Manufacturers (2017-2022) &(USD/MT)
    Table 20. Global Sulphonamides Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Sulphonamides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sulphonamides as of 2021)
    Table 22. Sulphonamides Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Sulphonamides Product Offered
    Table 24. Date of Manufacturers Enter into Sulphonamides Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Sulphonamides Sales by Type (2017-2022) & (K MT)
    Table 27. Global Sulphonamides Sales by Type (2023-2028) & (K MT)
    Table 28. Global Sulphonamides Sales Share by Type (2017-2022)
    Table 29. Global Sulphonamides Sales Share by Type (2023-2028)
    Table 30. Global Sulphonamides Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Sulphonamides Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Sulphonamides Revenue Share by Type (2017-2022)
    Table 33. Global Sulphonamides Revenue Share by Type (2023-2028)
    Table 34. Sulphonamides Price by Type (2017-2022) & (USD/MT)
    Table 35. Global Sulphonamides Price Forecast by Type (2023-2028) & (USD/MT)
    Table 36. Global Sulphonamides Sales by Application (2017-2022) & (K MT)
    Table 37. Global Sulphonamides Sales by Application (2023-2028) & (K MT)
    Table 38. Global Sulphonamides Sales Share by Application (2017-2022)
    Table 39. Global Sulphonamides Sales Share by Application (2023-2028)
    Table 40. Global Sulphonamides Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Sulphonamides Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Sulphonamides Revenue Share by Application (2017-2022)
    Table 43. Global Sulphonamides Revenue Share by Application (2023-2028)
    Table 44. Sulphonamides Price by Application (2017-2022) & (USD/MT)
    Table 45. Global Sulphonamides Price Forecast by Application (2023-2028) & (USD/MT)
    Table 46. North America Sulphonamides Sales by Type (2017-2022) & (K MT)
    Table 47. North America Sulphonamides Sales by Type (2023-2028) & (K MT)
    Table 48. North America Sulphonamides Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Sulphonamides Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Sulphonamides Sales by Application (2017-2022) & (K MT)
    Table 51. North America Sulphonamides Sales by Application (2023-2028) & (K MT)
    Table 52. North America Sulphonamides Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Sulphonamides Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Sulphonamides Sales by Country (2017-2022) & (K MT)
    Table 55. North America Sulphonamides Sales by Country (2023-2028) & (K MT)
    Table 56. North America Sulphonamides Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Sulphonamides Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Sulphonamides Sales by Type (2017-2022) & (K MT)
    Table 59. Europe Sulphonamides Sales by Type (2023-2028) & (K MT)
    Table 60. Europe Sulphonamides Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Sulphonamides Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Sulphonamides Sales by Application (2017-2022) & (K MT)
    Table 63. Europe Sulphonamides Sales by Application (2023-2028) & (K MT)
    Table 64. Europe Sulphonamides Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Sulphonamides Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Sulphonamides Sales by Country (2017-2022) & (K MT)
    Table 67. Europe Sulphonamides Sales by Country (2023-2028) & (K MT)
    Table 68. Europe Sulphonamides Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Sulphonamides Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Sulphonamides Sales by Type (2017-2022) & (K MT)
    Table 71. Asia Pacific Sulphonamides Sales by Type (2023-2028) & (K MT)
    Table 72. Asia Pacific Sulphonamides Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Sulphonamides Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Sulphonamides Sales by Application (2017-2022) & (K MT)
    Table 75. Asia Pacific Sulphonamides Sales by Application (2023-2028) & (K MT)
    Table 76. Asia Pacific Sulphonamides Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Sulphonamides Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Sulphonamides Sales by Region (2017-2022) & (K MT)
    Table 79. Asia Pacific Sulphonamides Sales by Region (2023-2028) & (K MT)
    Table 80. Asia Pacific Sulphonamides Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Sulphonamides Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Sulphonamides Sales by Type (2017-2022) & (K MT)
    Table 83. Latin America Sulphonamides Sales by Type (2023-2028) & (K MT)
    Table 84. Latin America Sulphonamides Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Sulphonamides Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Sulphonamides Sales by Application (2017-2022) & (K MT)
    Table 87. Latin America Sulphonamides Sales by Application (2023-2028) & (K MT)
    Table 88. Latin America Sulphonamides Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Sulphonamides Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Sulphonamides Sales by Country (2017-2022) & (K MT)
    Table 91. Latin America Sulphonamides Sales by Country (2023-2028) & (K MT)
    Table 92. Latin America Sulphonamides Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Sulphonamides Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Sulphonamides Sales by Type (2017-2022) & (K MT)
    Table 95. Middle East and Africa Sulphonamides Sales by Type (2023-2028) & (K MT)
    Table 96. Middle East and Africa Sulphonamides Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Sulphonamides Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Sulphonamides Sales by Application (2017-2022) & (K MT)
    Table 99. Middle East and Africa Sulphonamides Sales by Application (2023-2028) & (K MT)
    Table 100. Middle East and Africa Sulphonamides Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Sulphonamides Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Sulphonamides Sales by Country (2017-2022) & (K MT)
    Table 103. Middle East and Africa Sulphonamides Sales by Country (2023-2028) & (K MT)
    Table 104. Middle East and Africa Sulphonamides Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Sulphonamides Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Abbott Laboratories Corporation Information
    Table 107. Abbott Laboratories Description and Major Businesses
    Table 108. Abbott Laboratories Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 109. Abbott Laboratories Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Abbott Laboratories Recent Developments
    Table 111. Boehringer Ingelheim Pharmaceuticals Corporation Information
    Table 112. Boehringer Ingelheim Pharmaceuticals Description and Major Businesses
    Table 113. Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 114. Boehringer Ingelheim Pharmaceuticals Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Boehringer Ingelheim Pharmaceuticals Recent Developments
    Table 116. Bayer AG Corporation Information
    Table 117. Bayer AG Description and Major Businesses
    Table 118. Bayer AG Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 119. Bayer AG Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Bayer AG Recent Developments
    Table 121. GlaxoSmithKline Corporation Information
    Table 122. GlaxoSmithKline Description and Major Businesses
    Table 123. GlaxoSmithKline Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 124. GlaxoSmithKline Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. GlaxoSmithKline Recent Developments
    Table 126. King Pharmaceuticals Corporation Information
    Table 127. King Pharmaceuticals Description and Major Businesses
    Table 128. King Pharmaceuticals Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 129. King Pharmaceuticals Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. King Pharmaceuticals Recent Developments
    Table 131. Mylan Pharmaceuticals Corporation Information
    Table 132. Mylan Pharmaceuticals Description and Major Businesses
    Table 133. Mylan Pharmaceuticals Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 134. Mylan Pharmaceuticals Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Mylan Pharmaceuticals Recent Developments
    Table 136. Novartis International AG Corporation Information
    Table 137. Novartis International AG Description and Major Businesses
    Table 138. Novartis International AG Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 139. Novartis International AG Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Novartis International AG Recent Developments
    Table 141. Pfizer Corporation Information
    Table 142. Pfizer Description and Major Businesses
    Table 143. Pfizer Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 144. Pfizer Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Pfizer Recent Developments
    Table 146. Par Pharmaceutical Corporation Information
    Table 147. Par Pharmaceutical Description and Major Businesses
    Table 148. Par Pharmaceutical Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 149. Par Pharmaceutical Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Par Pharmaceutical Recent Developments
    Table 151. Roche Holding AG Corporation Information
    Table 152. Roche Holding AG Description and Major Businesses
    Table 153. Roche Holding AG Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 154. Roche Holding AG Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Roche Holding AG Recent Developments
    Table 156. Sanofi Aventis Corporation Information
    Table 157. Sanofi Aventis Description and Major Businesses
    Table 158. Sanofi Aventis Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 159. Sanofi Aventis Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Sanofi Aventis Recent Developments
    Table 161. Stiefel Laboratories Corporation Information
    Table 162. Stiefel Laboratories Description and Major Businesses
    Table 163. Stiefel Laboratories Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 164. Stiefel Laboratories Sulphonamides Product Model Numbers, Pictures, Descriptions and Specifications
    Table 165. Stiefel Laboratories Recent Developments
    Table 166. Key Raw Materials Lists
    Table 167. Raw Materials Key Suppliers Lists
    Table 168. Sulphonamides Distributors List
    Table 169. Sulphonamides Customers List
    Table 170. Sulphonamides Market Trends
    Table 171. Sulphonamides Market Drivers
    Table 172. Sulphonamides Market Challenges
    Table 173. Sulphonamides Market Restraints
    Table 174. Research Programs/Design for This Report
    Table 175. Key Data Information from Secondary Sources
    Table 176. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sulphonamides Product Picture
    Figure 3. Global Sulphonamides Market Share by Type in 2021 & 2028
    Figure 3. Orally Absorbable Sulfonamide Product Picture
    Figure 4. Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) Product Picture
    Figure 5. Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) Product Picture
    Figure 6. Global Sulphonamides Market Share by Application in 2021 & 2028
    Figure 7. Skin Infections
    Figure 8. Gastro Intestinal Tract (GIT) Infection
    Figure 9. Meningitis
    Figure 10. Sulphonamides Report Years Considered
    Figure 11. Global Sulphonamides Sales 2017-2028 (K MT)
    Figure 12. Global Sulphonamides Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Sulphonamides Revenue 2017-2028 (US$ Million)
    Figure 14. Global Sulphonamides Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Sulphonamides Sales Market Share by Region (2017-2022)
    Figure 16. Global Sulphonamides Sales Market Share by Region (2023-2028)
    Figure 17. North America Sulphonamides Sales YoY (2017-2028) & (K MT)
    Figure 18. North America Sulphonamides Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Sulphonamides Sales YoY (2017-2028) & (K MT)
    Figure 20. Europe Sulphonamides Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Sulphonamides Sales YoY (2017-2028) & (K MT)
    Figure 22. Asia-Pacific Sulphonamides Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Sulphonamides Sales YoY (2017-2028) & (K MT)
    Figure 24. Latin America Sulphonamides Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Sulphonamides Sales YoY (2017-2028) & (K MT)
    Figure 26. Middle East & Africa Sulphonamides Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Sulphonamides Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Sulphonamides in the World: Market Share by Sulphonamides Revenue in 2021
    Figure 29. Global Sulphonamides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Sulphonamides Sales Market Share by Type (2017-2028)
    Figure 31. Global Sulphonamides Revenue Market Share by Type (2017-2028)
    Figure 32. Global Sulphonamides Sales Market Share by Application (2017-2028)
    Figure 33. Global Sulphonamides Revenue Market Share by Application (2017-2028)
    Figure 34. North America Sulphonamides Sales Market Share by Type (2017-2028)
    Figure 35. North America Sulphonamides Revenue Market Share by Type (2017-2028)
    Figure 36. North America Sulphonamides Sales Market Share by Application (2017-2028)
    Figure 37. North America Sulphonamides Revenue Market Share by Application (2017-2028)
    Figure 38. North America Sulphonamides Sales Share by Country (2017-2028)
    Figure 39. North America Sulphonamides Revenue Share by Country (2017-2028)
    Figure 40. U.S. Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Sulphonamides Sales Market Share by Type (2017-2028)
    Figure 43. Europe Sulphonamides Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Sulphonamides Sales Market Share by Application (2017-2028)
    Figure 45. Europe Sulphonamides Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Sulphonamides Sales Share by Country (2017-2028)
    Figure 47. Europe Sulphonamides Revenue Share by Country (2017-2028)
    Figure 48. Germany Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 49. France Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Sulphonamides Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Sulphonamides Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Sulphonamides Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Sulphonamides Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Sulphonamides Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Sulphonamides Revenue Share by Region (2017-2028)
    Figure 59. China Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 62. India Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Sulphonamides Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Sulphonamides Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Sulphonamides Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Sulphonamides Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Sulphonamides Sales Share by Country (2017-2028)
    Figure 74. Latin America Sulphonamides Revenue Share by Country (2017-2028)
    Figure 75. Mexico Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Sulphonamides Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Sulphonamides Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Sulphonamides Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Sulphonamides Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Sulphonamides Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Sulphonamides Revenue Share by Country (2017-2028)
    Figure 84. Turkey Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 86. UAE Sulphonamides Revenue (2017-2028) & (US$ Million)
    Figure 87. Sulphonamides Value Chain
    Figure 88. Sulphonamides Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
Boehringer Ingelheim Pharmaceuticals
Bayer AG
GlaxoSmithKline
King Pharmaceuticals
Mylan Pharmaceuticals
Novartis International AG
Pfizer
Par Pharmaceutical
Roche Holding AG
Sanofi Aventis
Stiefel Laboratories
Frequently Asked Questions
Sulphonamides report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Sulphonamides report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Sulphonamides report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports